Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea‐predominant irritable bowel syndrome
暂无分享,去创建一个
[1] S. Maxion-Bergemann,et al. Costs of irritable bowel syndrome in the UK and US , 2012, PharmacoEconomics.
[2] Aleksandar Milosavljevic,et al. Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. , 2011, Gastroenterology.
[3] R. Sartor,et al. Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome. , 2011, American journal of physiology. Gastrointestinal and liver physiology.
[4] Sebastian Tims,et al. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. , 2011, Gastroenterology.
[5] C. Lee,et al. Microbial community and metabolomic comparison of irritable bowel syndrome faeces , 2011, Journal of medical microbiology.
[6] B. Haas,et al. Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. , 2011, Genome research.
[7] R. Knight,et al. UniFrac: an effective distance metric for microbial community comparison , 2011, The ISME Journal.
[8] W. Chey,et al. Rifaximin therapy for patients with irritable bowel syndrome without constipation. , 2011, The New England journal of medicine.
[9] R. Sartor,et al. Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome , 2010, Gut pathogens.
[10] Anders F. Andersson,et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. , 2010, Gastroenterology.
[11] E. K. Kemsley,et al. Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota , 2010, BMC gastroenterology.
[12] Robert C. Edgar,et al. BIOINFORMATICS APPLICATIONS NOTE , 2001 .
[13] Courtney J. Robinson,et al. From Structure to Function: the Ecology of Host-Associated Microbial Communities , 2010, Microbiology and Molecular Biology Reviews.
[14] Patrick D. Schloss,et al. The Effects of Alignment Quality, Distance Calculation Method, Sequence Filtering, and Region on the Analysis of 16S rRNA Gene-Based Studies , 2010, PLoS Comput. Biol..
[15] J. Tack,et al. Altered intestinal microbiota in irritable bowel syndrome , 2010, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[16] William A. Walters,et al. QIIME allows analysis of high-throughput community sequencing data , 2010, Nature Methods.
[17] Rob Knight,et al. PyNAST: a flexible tool for aligning sequences to a template alignment , 2009, Bioinform..
[18] F. Shanahan,et al. A Molecular Analysis of Fecal and Mucosal Bacterial Communities in Irritable Bowel Syndrome , 2010, Digestive Diseases and Sciences.
[19] J. Nikkilä,et al. Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification. , 2009, World journal of gastroenterology.
[20] R. Knight,et al. Bacterial Community Variation in Human Body Habitats Across Space and Time , 2009, Science.
[21] L. Paulin,et al. Multilayered epithelium in a rat model and human Barrett's esophagus: Similar expression patterns of transcription factors and differentiation markers , 2008, BMC gastroenterology.
[22] W. Chey,et al. Bifidobacterium infantis 35624: a novel probiotic for the treatment of irritable bowel syndrome. , 2009, Reviews in gastroenterological disorders.
[23] J. Doré,et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota , 2009, Inflammatory bowel diseases.
[24] M. Samsom,et al. Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients. , 2009, World journal of gastroenterology.
[25] W. Chey,et al. An Evidence-Based Position Statement on the Management of Irritable Bowel Syndrome , 2008, The American Journal of Gastroenterology.
[26] B. Roe,et al. A core gut microbiome in obese and lean twins , 2008, Nature.
[27] Y. Ringel,et al. Alterations in the intestinal microbiota and functional bowel symptoms. , 2009, Gastrointestinal endoscopy clinics of North America.
[28] R. Knight,et al. The influence of sex, handedness, and washing on the diversity of hand surface bacteria , 2008, Proceedings of the National Academy of Sciences.
[29] J. Doré,et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients , 2008, Proceedings of the National Academy of Sciences.
[30] M. Kamm,et al. Review article: the psychoneuroimmunology of irritable bowel syndrome – an exploration of interactions between psychological, neurological and immunological observations , 2008, Alimentary pharmacology & therapeutics.
[31] Anders F. Andersson,et al. Comparative Analysis of Human Gut Microbiota by Barcoded Pyrosequencing , 2008, PloS one.
[32] R. Knight,et al. Error-correcting barcoded primers for pyrosequencing hundreds of samples in multiplex , 2008, Nature Methods.
[33] Weili Lin,et al. Effect of abuse history on pain reports and brain responses to aversive visceral stimulation: an FMRI study. , 2008, Gastroenterology.
[34] Lin Chang,et al. FUNCTIONAL BOWEL DISORDERS , 2018, The American Journal of Gastroenterology.
[35] J. Tiedje,et al. Naïve Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy , 2007, Applied and Environmental Microbiology.
[36] R. Knight,et al. Quantitative and Qualitative β Diversity Measures Lead to Different Insights into Factors That Structure Microbial Communities , 2007, Applied and Environmental Microbiology.
[37] E. Mardis,et al. An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.
[38] M. Pimentel,et al. Neomycin Improves Constipation-Predominant Irritable Bowel Syndrome in a Fashion That Is Dependent on the Presence of Methane Gas: Subanalysis of a Double-Blind Randomized Controlled Study , 2006, Digestive Diseases and Sciences.
[39] R. Satokari,et al. Prevalence and temporal stability of selected clostridial groups in irritable bowel syndrome in relation to predominant faecal bacteria. , 2006, Journal of medical microbiology.
[40] R. Mounzer,et al. A Randomized Double-Blind Placebo-Controlled Trial of Rifaximin in Patients with Abdominal Bloating and Flatulence , 2006, The American Journal of Gastroenterology.
[41] W. Jackson,et al. Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice , 2005, Gut.
[42] I. Rowland,et al. Relationship between dietary‐induced changes in intestinal commensal microflora and duodenojejunal myoelectric activity monitored by radiotelemetry in the rat in vivo , 2006, Experimental physiology.
[43] R JoséKlinger,et al. Irritable Bowel Syndrome , 2006 .
[44] R. Knight,et al. UniFrac: a New Phylogenetic Method for Comparing Microbial Communities , 2005, Applied and Environmental Microbiology.
[45] E. Purdom,et al. Diversity of the Human Intestinal Microbial Flora , 2005, Science.
[46] L. Chang,et al. Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact , 2005, Alimentary pharmacology & therapeutics.
[47] F. Bäckhed,et al. Host-Bacterial Mutualism in the Human Intestine , 2005, Science.
[48] A. Palva,et al. Analysis of the Fecal Microbiota of Irritable Bowel Syndrome Patients and Healthy Controls with Real-Time PCR , 2005, The American Journal of Gastroenterology.
[49] G. Vantrappen,et al. Interdigestive myoelectric complex in germ-free rats , 1989, Digestive Diseases and Sciences.
[50] Yu-jing Fan,et al. Intestinal microecology and quality of life in irritable bowel syndrome patients. , 2004, World journal of gastroenterology.
[51] H. Flint,et al. Oligonucleotide Probes That Detect Quantitatively Significant Groups of Butyrate-Producing Bacteria in Human Feces , 2003, Applied and Environmental Microbiology.
[52] P. Schoenfeld,et al. The epidemiology of irritable bowel syndrome in North America: a systematic review , 2002, American Journal of Gastroenterology.
[53] E. Zoetendal,et al. Mucosa-Associated Bacteria in the Human Gastrointestinal Tract Are Uniformly Distributed along the Colon and Differ from the Community Recovered from Feces , 2002, Applied and Environmental Microbiology.
[54] H. El‐Serag,et al. Health‐related quality of life among persons with irritable bowel syndrome: a systematic review , 2002, Alimentary pharmacology & therapeutics.
[55] F. Sundler,et al. Influence of microbial species on small intestinal myoelectric activity and transit in germ-free rats. , 2001, American journal of physiology. Gastrointestinal and liver physiology.
[56] H. Flint,et al. Phylogenetic Relationships of Butyrate-Producing Bacteria from the Human Gut , 2000, Applied and Environmental Microbiology.
[57] J. Doré,et al. Direct Analysis of Genes Encoding 16S rRNA from Complex Communities Reveals Many Novel Molecular Species within the Human Gut , 1999, Applied and Environmental Microbiology.
[58] E. Zoetendal,et al. Temperature Gradient Gel Electrophoresis Analysis of 16S rRNA from Human Fecal Samples Reveals Stable and Host-Specific Communities of Active Bacteria , 1998, Applied and Environmental Microbiology.
[59] G. Sturniolo,et al. [Irritable bowel syndrome]. , 1988, Giornale di clinica medica.
[60] A. Balsari,et al. The fecal microbial population in the irritable bowel syndrome. , 1982, Microbiologica.
[61] R. E. Buchanan,et al. Bergey's Manual of Determinative Bacteriology. , 1975 .
[62] S. T. Cowan. Bergey's Manual of Determinative Bacteriology , 1948, Nature.